SCHEMBL28089117

SCHEMBL28089117

COC(=O)Cc1ccc(Cl)cn1

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
PTK2 Q05397 1/20 0.45
RAB9A P51151 4/20 0.44
NPC1 O15118 3/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
PTGS2 P35354 1/20 0.42
TSHR P16473 1/20 0.41
MAPT P10636 1/20 0.41
TP53 P04637 1/20 0.41
POLB P06746 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAOB P27338 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29155067 0.89 PTK2 (0.41) ALDH1A1PTK2RAB9ANPC1TDP1
SCHEMBL19385660 0.83 CYP11B1 (0.49) PTK2NPC1TDP1L3MBTL1PTGS2
SCHEMBL13172597 0.83 MAPT (0.50) ALDH1A1RAB9ATDP1MAPTPOLB
SCHEMBL30106072 0.82 HSP90AB1 (0.47) ALDH1A1RAB9ANPC1
SCHEMBL15710323 0.82 HSP90AB1 (0.47) ALDH1A1RAB9ANPC1
SCHEMBL10174364 0.81 RAB9A (0.44) ALDH1A1RAB9ANPC1MAPT
SCHEMBL26046019 0.80 TDP1 (0.51) ALDH1A1PTK2RAB9ANPC1TDP1
SCHEMBL9267515 0.79 MBOAT4 (0.42) ALDH1A1RAB9ANPC1MAPTTP53
SCHEMBL31028364 0.79 MBOAT4 (0.42) ALDH1A1RAB9ANPC1MAPTTP53
SCHEMBL30094494 0.79 KDM4E (0.42) ALDH1A1RAB9ANPC1L3MBTL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111116576-A Quinolizinone compound and preparation method thereof 北京师范大学 2020-05-08 CN disclosed
CN-106349156-A Pyridine-2-amides capable of being used as CB2 agonist 霍夫曼-拉罗奇有限公司 2017-01-25 CN disclosed
CN-103608332-B Pyridine-2-amides useful as CB2 agonists 霍夫曼-拉罗奇有限公司 2016-09-28 CN disclosed